HCG日孕酮水平与体外受精-胚胎移植治疗结局的关系探讨

发布时间：2018-03-27 05:14

  本文选题：HCG日　切入点：孕酮浓度　出处：《暨南大学学报(自然科学与医学版)》2017年02期

【摘要】：目的:探讨在体外受精-胚胎移植(IVF-ET)控制性促排卵(COH)过程中,人绒毛膜促性腺激素(HCG)日孕酮(P)浓度与IVF-ET治疗结局的关系.方法:分析350个IVF-ET取卵周期,均采用黄体中期垂体降调节方案,按HCG日血清孕酮浓度分为3组,分别为A组67例(1.0≤P2.0 nmol/L)、B组133例(2.0≤P3.0 nmol/L)、C组150例(3.0≤P4.77 nmol/L).比较3组患者的基本临床资料、卵子及胚胎资料、周期取消及妊娠结局情况.结果:HCG日血清孕酮浓度在3.0~4.77 nmol/L组时,获卵数、MII卵数及受精数均高于其他组;同时种植率及妊娠率亦最高.结论:HCG日血清孕酮浓度水平在3.0~4.77 nmol/L之间能获得更成熟的卵子,同时不增加因多卵泡发育引起卵巢过度刺激综合征(OHSS)导致的周期取消率.
[Abstract]:Objective: to investigate the relationship between the concentration of human chorionic gonadotropin (HCG) day progesterone and the outcome of IVF-ET during IVF-ET-controlled ovulation induction during in vitro fertilization and embryo transfer. All patients were divided into three groups according to the serum progesterone concentration of HCG day, which were divided into three groups: group A, 67 cases (group A, n = 67) with 1.0 鈮，

本文编号：1670139